Retroviruses: Molecular Biology, Immunology and Pathogenesis

A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Viral Pathogens".

Deadline for manuscript submissions: 31 January 2025 | Viewed by 1638

Special Issue Editor


E-Mail Website
Guest Editor
Molecular Microbiology and Structural Biochemistry, MMSB-IBCP, UMR 5086, CNRS, University of Lyon, 7 Passage du Vercors, CEDEX 07, 69367 Lyon, France
Interests: retrovirology; structural virology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Infections by retroviruses constitute a major health issue in humans, with Human Immunodeficiency Virus (HIV) being the etiological agent of AIDS, and Human T-Cell Leukemia Virus type 1 causing adult T-cell leukemia or a neurodegenerative disease named HTLV-1-associated myelopathy/tropical spastic paraparesis.

Retroviral infections are also a major veterinary problem as they induce various pathologies in a wide range of domestic and wild animals, from poultry, cats, cattle and horses to lions, monkeys and koalas.

It is interesting to note that some exogenous infections can lead to the permanent insertion of retroviral elements in the genome of the infected species. These endogenous retroviruses (ERVs) are estimated to represent 1 to 5 percent of the human genome. They have influenced the evolution of some species, and their activation can also be linked to several diseases.

This wide variety of retroviral species and their associated pathogenicity involves specific replication strategies, regulatory mechanisms, virus–host interactions and/or escape from host restriction factors or from the host’s immune system. New understandings of these different aspects have recently been obtained with the development of new imaging and analysis techniques.

This Special Issue of Pathogens aims to bring together articles or reviews dealing with the most recent developments of all aspects of the research on human and animal retroviruses, from molecular and structural biology or recent -omics analysis, to virus–cell interactions, immunology and disease development, control or therapy in infected individuals. This will provide a comprehensive and up-to-date overview of the mechanisms underlying retroviral infections, replication, activation, host–virus interactions, and pathogenicity.

We look forward to receiving your contributions.

Dr. Christophe Guillon
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • retroviruses
  • retroviral infections
  • viral replication
  • host-virus interactions
  • molecular and structural biology
  • virus-cell interactions
  • immunology
  • therapy

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

14 pages, 7670 KiB  
Review
“It’s Only a Model”: When Protein Structure Predictions Need Experimental Validation, the Case of the HTLV-1 Tax Protein
by Christophe Guillon, Xavier Robert and Patrice Gouet
Pathogens 2024, 13(3), 241; https://0-doi-org.brum.beds.ac.uk/10.3390/pathogens13030241 - 08 Mar 2024
Viewed by 1421
Abstract
Human T-cell Leukemia Virus type 1 (HTLV-1) is a human retrovirus responsible for leukaemia in 5 to 10% of infected individuals. Among the viral proteins, Tax has been described as directly involved in virus-induced leukemogenesis. Tax is therefore an interesting therapeutic target. However, [...] Read more.
Human T-cell Leukemia Virus type 1 (HTLV-1) is a human retrovirus responsible for leukaemia in 5 to 10% of infected individuals. Among the viral proteins, Tax has been described as directly involved in virus-induced leukemogenesis. Tax is therefore an interesting therapeutic target. However, its 3D structure is still unknown and this hampers the development of drug-design-based therapeutic strategies. Several algorithms are available that can be used to predict the structure of proteins, particularly with the recent appearance of artificial intelligence (AI)-driven pipelines. Here, we review how the structure of Tax is predicted by several algorithms using distinct modelling strategies. We discuss the consequences for the understanding of Tax structure/function relationship, and more generally for the use of structure models for modular and/or flexible proteins, which are frequent in retroviruses. Full article
(This article belongs to the Special Issue Retroviruses: Molecular Biology, Immunology and Pathogenesis)
Show Figures

Graphical abstract

Back to TopTop